Showing results (21-30 of 26) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Molecules (Basel, Switzerland)|December 11, 2019
The Role of c-Met as a Biomarker and Player in Innate and Acquired Resistance in Non-Small-Cell Lung Cancer: Two New Mutations Warrant Further StudiesNele Van Der Steen, Karen Zwaenepoel, Giulia Mazzaschi, et al.The Lancet. Oncology|June 24, 2010
Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trialRoy S Herbst, Yan Sun, Wilfried E E Eberhardt, et al.Lung Cancer (Amsterdam, Netherlands)|August 21, 2009
A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancerGiorgio V Scagliotti, Paul Germonpré, Leon Bosquée, et al.Cancers|August 29, 2018
A Multicenter Study to Assess <i>EGFR</i> Mutational Status in Plasma: Focus on an Optimized Workflow for Liquid Biopsy in a Clinical SettingLaure Sorber, Karen Zwaenepoel, Koen De Winne, et al.Lung Cancer (Amsterdam, Netherlands)|January 2, 2018
Does nivolumab for progressed metastatic lung cancer fulfill its promises? An efficacy and safety analysis in 20 general hospitalsKurt G Tournoy, Michiel Thomeer, Paul Germonpré, et al.Journal of Hematology & Oncology|January 24, 2025
WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcomeZwi N Berneman, Maxime De Laere, Paul Germonpré, et al.Pageof 3